Sutapa Mukhopadhyay Selected Research

Sutapa Mukhopadhyay Research Topics

Disease

7	Drug Overdose 01/2024 - 01/2018
6	Breast Neoplasms (Breast Cancer) 07/2010 - 01/2004
6	Neoplasms (Cancer) 07/2010 - 01/2004
4	Lung Injury 05/2010 - 01/2006
3	Opiate Overdose 01/2022 - 01/2018
3	Gastroparesis 12/2018 - 05/2010
2	Inflammation (Inflammations) 05/2010 - 07/2009
2	Lung Diseases (Lung Disease) 09/2008 - 01/2006
2	Adenocarcinoma 10/2006 - 05/2006
1	Carcinoma (Carcinomatosis) 11/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Obesity 01/2022
1	DiGeorge Syndrome (Syndrome, DiGeorge) 12/2018
1	Wounds and Injuries (Trauma) 10/2018
1	Multiple Myeloma 10/2013
1	Fibrosis (Cirrhosis) 09/2008
1	Body Weight (Weight, Body) 01/2006
1	Ehrlich Tumor Carcinoma 04/2003

Drug/Important Bio-Agent (IBA)

5	anthraceneIBA 07/2010 - 05/2006
4	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2018
4	AntioxidantsIBA 08/2011 - 04/2003
4	2-chloroethyl ethyl sulfideIBA 05/2010 - 01/2006
4	Mustard Gas (Sulfur Mustard)IBA 05/2010 - 01/2006
3	Controlled SubstancesIBA 01/2023 - 01/2020
3	Caseins (Casein)FDA Link 07/2010 - 10/2006
3	GABA-A Receptors (GABA(A) Receptor)IBA 07/2010 - 05/2006
2	BenzodiazepinesIBA 01/2023 - 01/2022
2	RV 538 (PDMP)IBA 01/2020 - 01/2018
2	sapropterin (tetrahydrobiopterin)FDA Link 12/2018 - 05/2010
2	Transcription Factors (Transcription Factor)IBA 08/2011 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 07/2010 - 04/2008
2	Liposomes (Liposome)IBA 05/2010 - 07/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 09/2008
2	EnzymesIBA 11/2008 - 04/2003
2	Soybean Proteins (Soy Protein)IBA 04/2008 - 10/2006
2	CholesterolIBA 04/2008 - 05/2006
2	LigandsIBA 04/2008 - 05/2006
2	Superoxide DismutaseIBA 01/2006 - 01/2004
1	Illicit Drugs (Recreational Drugs)IBA 01/2024
1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2024
1	erdafitinibIBA 11/2023
1	PlatinumIBA 11/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2023
1	B7-H1 AntigenIBA 11/2023
1	Programmed Cell Death 1 ReceptorIBA 11/2023
1	Xylazine (Xylazin)IBA 01/2023
1	Phentermine (Adipex-P)FDA LinkGeneric 01/2023
1	Messenger RNA (mRNA)IBA 12/2018
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2018
1	Hazardous Substances (Hazardous Materials)IBA 10/2018
1	Carbon MonoxideIBA 10/2018
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2018
1	Heroin (Diamorphine)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 10/2013
1	PanobinostatIBA 10/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2013
1	Glutamate-Cysteine LigaseIBA 08/2011
1	PK 11195 (PK11195)IBA 07/2010
1	CarcinogensIBA 07/2010
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2010
1	Mitogen-Activated Protein KinasesIBA 05/2010
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 05/2010
1	Syntex adjuvant formulationIBA 05/2010
1	Biomarkers (Surrogate Marker)IBA 11/2008
1	Diacylglycerol Cholinephosphotransferase (Cholinephosphotransferase)IBA 11/2008
1	Phosphatidylcholines (Phosphatidylcholine)IBA 11/2008
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2008
1	Free RadicalsIBA 09/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2006
1	Nucleoside-TriphosphataseIBA 05/2006
1	Ethanol (Ethyl Alcohol)IBA 01/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2004
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2004
1	Caffeine (No Doz)FDA LinkGeneric 04/2003

Therapy/Procedure

3	Therapeutics 11/2023 - 10/2013
1	Aftercare (After-Treatment) 11/2023
1	Drug Therapy (Chemotherapy) 11/2023